Cancer research is one of the fastest-growing areas in clinical development
With thousands of active trials exploring new treatments, immunotherapies, and personalized medicine. But oncology studies are also among the hardest to enroll.
Patients often face treatment hesitancy due to side effects or heavy time commitments, while strict inclusion criteria limit eligibility. At the same time, competition for participants across multiple concurrent oncology trials slows progress and drives up costs. Diversity remains another major gap, with underrepresentation of minority groups impacting trial validity and regulatory alignment.
The result for sponsors and CROs: extended timelines, escalating budgets, and increased risk of trial failure without the right recruitment partner
OMNI CRS Solutions for Oncology Recruitment
OMNI CRS combines a compliance-first model with a powerful performance marketing engine to deliver high-intent, conversion-ready oncology patients. Our approach is designed to overcome oncology’s unique recruitment challenges:
- Multi-channel strategies: campaigns across email, social media, search, patient advocacy partnerships, and oncology site networks.
- Content-driven engagement: educational resources and caregiver-focused messaging that improve awareness and trust
- Compliance at every step: HIPAA, GDPR, and FDA alignment, supported by proprietary fraud-prevention and strict data validation
- Diversity and inclusion: targeted outreach to underrepresented populations, with multilingual content and community partnerships
With OMNI CRS, oncology enrollment becomes faster, more predictable, and more representative.
Impact for Sponsors, CROs, and Sites.
Partnering with OmniCRS provides measurable recruitment advantages:
Accelerated timelines
through precision targeting and optimized outreach.
Forecastable pipelines
using real-time dashboards, prevalence modeling, and site-level alignment.
Lower cost-per-patient
compared to site-led or manual recruitment campaigns.
Improved retention
by delivering pre-qualified patients who are more likely to stay engaged.
Proven Results in Oncology Recruitment
Our recruitment engine is designed to reach and engage patients where they are, with tailored strategies that build trust:
OMNI CRS has a track record of success across oncology indications. For example:
- A Phase II breast cancer trial that reached full enrollment ahead of sponsor timelines.
- Multi-site oncology campaigns that reduced recruitment costs by 30–35% compared to traditional approaches.
- Diversity-focused campaigns that increased minority enrollment, supporting FDA and NIH requirements
These results highlight OMNI CRS’ ability to scale recruitment solutions while maintaining compliance and quality.
Proprietary fraud-prevention
HIPAA / GDPR / FDA compliance
Continuous quality monitoring
Partner With OMNI CRS
Your oncology trial deserves a recruitment partner that understands the complexity of cancer studies and can deliver speed, diversity, and compliance. OMNI CRS transforms oncology patient acquisition into a strategic advantage for sponsors, CROs, and research sites.